| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 02/27/2013 | CN102942524A Preparation method of quinoline derivative |
| 02/27/2013 | CN102942429A Method for preparing aza or thia aryl biaryl compound by aid of palladium and carbon catalysts |
| 02/26/2013 | US8383836 Methods and systems for treating cell proliferation disorders with psoralen derivatives |
| 02/26/2013 | US8383819 Method for producing 4-oxoquinoline compound |
| 02/26/2013 | US8383818 Functionally selective alpha2C adrenoreceptor agonists |
| 02/26/2013 | US8383647 Quinoline derivative |
| 02/26/2013 | US8383094 Hepatitis C virus inhibitors |
| 02/21/2013 | WO2013025560A1 Sweet flavor modifier |
| 02/21/2013 | US20130045989 Stabilized crystal of 2-ethyl-3,7-dimethyl-6-(4-(trifluoromethoxy)phenoxy)quinoline-4-yl methyl carbonate, process for producing the crystal, and agricultural chemical composition comprising the crystal |
| 02/21/2013 | CA2841012A1 Sweet flavor modifier |
| 02/20/2013 | EP2559686A1 Therapeutic quinoline and naphthalene derivatives |
| 02/20/2013 | EP2558449A1 Novel 3,3-dimethyl tetrahydroquinoline derivatives |
| 02/19/2013 | US8378107 Heteroaryl antagonists of prostaglandin D2 receptors |
| 02/19/2013 | US8378106 Method for preparing argatroban monohydrate and a process for its synthesis |
| 02/19/2013 | US8378099 Boronic ester and acid compounds, synthesis and uses |
| 02/19/2013 | US8377930 PDE10 inhibitors and related compositions and methods |
| 02/19/2013 | CA2606675C Process for preparing (alpha s, beta r)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol |
| 02/14/2013 | WO2013020672A1 Process for the preparation of aripiprazole |
| 02/14/2013 | WO2012025237A9 Substituted 2-amino-quinoline-3-carboxamides as kcnq2/3 modulators |
| 02/14/2013 | US20130041046 Sweet flavor modifier |
| 02/14/2013 | US20130040975 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 02/14/2013 | US20130038515 Novel organic compound and organic light-emitting device including the same |
| 02/13/2013 | EP2556856A1 6-Cyano-substituted Pyrido[2,3-d]pyrimidines as Adenosin Rezeptor Ligands for the Treatment of Cardiovascular Diseases |
| 02/13/2013 | EP2556831A1 3,4-Dihydro-4-oxo-5-aryl-pyrido[2,3-d]pyrimidine-6-carbonitriles as Adenosin Receptor Ligands for Treatment of Cardiovascular Diseases |
| 02/13/2013 | CN102933551A Hydrated crystalline forms of n-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]-quinolin-4-yl}oxy)phenyl]-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide |
| 02/13/2013 | CN102933550A Quinoline derivatives as fungicides |
| 02/13/2013 | CN102933530A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 02/13/2013 | CN102924375A Talnetant intermediate, preparation method and applications thereof |
| 02/13/2013 | CN102924374A Preparation method for quinoline-4-carboxylic acid derivative |
| 02/13/2013 | CN101808999B Quinoline derivatives as 5HT5A receptor antagonists |
| 02/13/2013 | CN101679269B Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one as agonist of the beta 2 adrenergic receptor |
| 02/12/2013 | US8372981 Nitrogen-containing aromatic derivatives |
| 02/12/2013 | CA2583920C Non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 02/12/2013 | CA2574464C Substituted quinolones |
| 02/07/2013 | WO2013017977A1 Compositions and methods for the treatment of cancer |
| 02/07/2013 | WO2013017654A1 Novel estrogen receptor ligands |
| 02/07/2013 | US20130035328 Antiviral compounds and methods |
| 02/07/2013 | US20130035327 Modulators of ATP-Binding Cassette Transporters |
| 02/07/2013 | US20130035312 Cathepsin cysteine protease inhibiors |
| 02/07/2013 | CA2842719A1 Novel estrogen receptor ligands |
| 02/06/2013 | EP2552892A1 Efficient synthesis for the preparation of montelukast and novel crystalline form of intermediates therein |
| 02/06/2013 | CN202717730U Production equipment of rebamipide |
| 02/06/2013 | CN202717729U Synthesis equipment of rebamipide |
| 02/06/2013 | CN1993327B 3-Carbamoyl-2-pyridone derivative |
| 02/06/2013 | CN102911116A Metal-chelated azo compact disc dye preparation method |
| 02/06/2013 | CN102603627B Naphthlamide derivative used as protein kinase inhibitor and histone deacetylase inhibitor and preparation method of naphthlamide derivative |
| 02/06/2013 | CN101679272B Triazolo [1, 5-a] quinolines as adenosine A3 receptor ligands |
| 02/06/2013 | CN101437801B Process for production of 4-oxoquinoline compound |
| 02/06/2013 | CN101395106B Dibenzoanthracene compound and organic light emitting device having the same |
| 02/05/2013 | US8367834 Process for preparing Montelukast and salts thereof |
| 02/05/2013 | US8367833 Process for producing 6-aryloxyquinoline derivative and intermediate therefor |
| 02/05/2013 | US8367702 Quinolone derivative |
| 02/05/2013 | US8367038 Therameutin modulators |
| 01/31/2013 | WO2013014569A1 Quinolinyl glucagon receptor modulators |
| 01/31/2013 | WO2013014060A1 Substituted quinolines and their use as medicaments |
| 01/31/2013 | US20130030180 Methods of Facilitating Neural Cell Survival Using GDNF Family Ligand (GFL) Mimetics or RET Signaling Pathway Activators |
| 01/31/2013 | US20130029942 Compounds and therapeutical uses thereof |
| 01/31/2013 | US20130029941 7,11-methanocycloocta [b] quinoline derivative as highly functionalizable acetylcholinesterase inhibitors |
| 01/31/2013 | CA2843022A1 Substituted quinolines and their use as medicaments |
| 01/31/2013 | CA2841237A1 Quinolinyl glucagon receptor modulators |
| 01/30/2013 | CN102898369A 3-amino-7-bromoquinoline-2-ethyl formate and preparation method thereof |
| 01/30/2013 | CN102898368A 8-hydroxyquinoline manganese nanorods prepared by sonochemical process |
| 01/30/2013 | CN102898367A Preparation method of pitavastatin calcium crude drug midbody |
| 01/30/2013 | CN102898366A Method for one-step preparation of 2-methylquinoline |
| 01/30/2013 | CN102898264A Catalytic preparation process for aromatic nitrile or heteroaromatic nitrile |
| 01/29/2013 | US8362463 Organometallic complexes |
| 01/29/2013 | US8362264 Compositions and methods for the treatment of disease associated with Trp-p8 expression |
| 01/29/2013 | US8362253 Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 01/29/2013 | US8362252 Carbostyril compound |
| 01/29/2013 | US8362112 Cure accelerators for anaerobic curable compositions |
| 01/29/2013 | US8362035 Crystalline forms of a potent HCV inhibitor |
| 01/29/2013 | US8362034 Quinoline compound, and composition containing centipede extract or compounds isolated therefrom for prevention and treatment of cardiovascular disease |
| 01/29/2013 | US8361500 Tablet formulations containing 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one salts and tablets made therefrom |
| 01/24/2013 | WO2013012199A1 Capsule formulation comprising montelukast and levocetirizine |
| 01/24/2013 | WO2013011930A1 Method for producing optically active tetrahydroquinoline |
| 01/24/2013 | US20130023528 Prolylhydroxylase inhibitors and methods of use |
| 01/24/2013 | US20130023518 Novel 3,3-dimethyl tetrahydroquinoline derivatives |
| 01/23/2013 | EP2547658A1 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 01/23/2013 | EP2547657A1 Purification tags of synthetic peptides and proteins |
| 01/23/2013 | CN101506328B Organic electroluminescent device material and organic electroluminescent device |
| 01/22/2013 | US8357702 Bicyclic derivatives as modulators of voltage gated ion channels |
| 01/22/2013 | US8357700 2,3-disubstituted piperidine orexin receptor antagonists |
| 01/22/2013 | CA2537812C C-met modulators and method of use |
| 01/22/2013 | CA2382779C Chiral ligands, transition-metal complexes thereof and uses thereof in asymmetric reactions |
| 01/17/2013 | WO2013007676A1 Aminomethyl quinolone compounds |
| 01/17/2013 | US20130018071 Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 01/17/2013 | US20130015431 Lithium metal quinolates and process for preparation thereof as good emitting, interface materials as well as n-type dopent for organic electronic devices |
| 01/17/2013 | CA2839395A1 Aminomethyl quinolone compounds |
| 01/16/2013 | EP2545038A1 Hydrated crystalline forms of n-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]-quinolin-4-yl}oxy)phenyl]-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide |
| 01/16/2013 | CN102884050A Stable crystal form of 2-ethyl-3, 7-dimethyl-6-(4-(trifluoromethoxy) phenoxy)quinoline-4-ylmethyl carbonate, method of manufacturing same and agricultural chemical composition containing crystals of same |
| 01/16/2013 | CN102875464A 3-Schiff base-2(1H)-quinolinone derivative and preparation method and application thereof |
| 01/16/2013 | CN102875274A Polyfluorinated aromatic ether compounds and synthesis method and application thereof |
| 01/16/2013 | CN102875273A Synthetic method of heteroaryl ether |
| 01/16/2013 | CN101878027B Multitarget compounds active at a PPAR and cannabinoid receptor |
| 01/15/2013 | US8354429 Inhibitors of human immunodeficiency virus replication |
| 01/15/2013 | US8354428 Solid state forms of laquinimod and its sodium salt |
| 01/15/2013 | US8354413 Quinolin-4-one and 4-oxodihydrocinnoline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP) |
| 01/10/2013 | WO2013005157A1 Sulfone derivatives and their use as pkm2 modulators for the treatment of cancer |
| 01/10/2013 | WO2012150537A3 Novel solid forms of antibiotics |
| 01/10/2013 | US20130012536 Modulators of atp-binding cassette transporters |